Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Cancer Journal (Sudbury, Mass.)|August 16, 2021
Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted TherapiesNil Albiol, Carol MorenoCurrent Opinion in Oncology|September 2, 2021
The road to chemotherapy-free treatment in chronic lymphocytic leukaemiaNil Albiol, Miguel Arguello-Tomas, Carol MorenoActa Haematologica|October 29, 2023
Frontline Therapy in Chronic Lymphocytic LeukemiaMiguel Arguello-Tomas, Nil Albiol, Carol MorenoJournal of Medical Case Reports|June 26, 2021
Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literatureNil Albiol, Silvana Novelli, Anna Mozos, et al.Cancer|December 11, 2025
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemiaMiguel Arguello-Tomas, Elionor Lynton-Pons, Nil Albiol, et al.Frontiers in Immunology|November 19, 2025
Endothelial dysfunction and hemostatic imbalance in CAR T-cell-associated toxicities: pathophysiological insights and the role of circulating biomarkersAna Belén Moreno-Castaño, Gontzal Iraola, Núria Martínez-Cibrián, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 28, 2022
mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipientsNil Albiol, Olga Aso, Lucía Gómez-Pérez, et al.Leukemia & Lymphoma|July 15, 2023
Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European centerMiguel Arguello-Tomas, Nil Albiol, Paola Jara, et al.Cancer|September 12, 2024
Risk scores predicting disease progression in early-stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracyMiguel Arguello-Tomas, Pablo Mozas, Nil Albiol, et al.Journal of Thrombosis and Thrombolysis|June 17, 2021
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19Mariana Corrochano, René Acosta-Isaac, Sergi Mojal, et al.Pageof 2